Form 4 · Filed Feb 17, 2026, 12:00 PM UTC
TNYA/Tenaya Therapeutics, Inc.
Ali Faraz — Chief Executive Officer
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | S | sell | 5,851 | $1 | $3,762 | 452,415 |
| Feb 17, 2026 | S | sell | 3,979 | $1 | $2,559 | 448,436 |
| Feb 17, 2026 | S | sell | 5,032 | $1 | $3,236 | 443,404 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-055442